AtriCure
CompanyUnited StatesFounded 2000
AtriCure develops 2 assets, the furthest in human trials (AtriClip LAA Exclusion System in post operative atrial fibrillation). Mostly device; based in the United States, founded in 2000.
- 2
- Assets
- Furthest
- Human trials
- 2
- Trials
- 0
- Signals
Pipeline
2Excludes the left atrial appendage to prevent postoperative atrial fibrillation and thromboembolism.
Human trials, Device, post operative atrial fibrillation, postoperative atrial fibrillation
Ablation clamp system for creating cardiac box lesions to prevent atrial fibrillation.
Human trials, Device, post operative atrial fibrillation, postoperative atrial fibrillation
Full company profiles: pipeline, trials, funding and people.
See ProIn the full profile
- Trials2
Updated 9 Oct 2026 · 9 sources